295
Participants
Start Date
October 14, 2015
Primary Completion Date
December 16, 2019
Study Completion Date
December 16, 2019
BMS-986156
Nivolumab
Local Institution, Westmead
Liverpool Cancer Therapy Center, Liverpool
Princess Alexandra Hospital, Brisbane
Linear Clinical Research Ltd, Nedlands
Local Institution, Zurich
Local Institution - 0012, Ghent
Cantonal Hospital St. Gallen, Sankt Gallen
Thomas Jefferson University Hospital, Philadelphia
Local Institution - 0014, Milan
Local Institution - 0015, Milan
Local Institution, Madrid
Local Institution, Madrid
Emory University, Atlanta
Institut Claudius Regaud, Toulouse
The West Clinic, P.C., Germantown
The Ohio State University, Columbus
Local Institution, Bonn
Local Institution, Paris
Local Institution, Freiburg im Breisgau
Institut Gustave Roussy, Vlllejuif
Local Institution, Würzburg
Providence Portland Medical Center, Portland
University Of Alabama At Birmingham, Birmingham
UCSD Moores Cancer Center, La Jolla
Local Institution, Edmonton
Local Institution, Toronto
Local Institution, Amsterdam
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY